Urology Research & Practice
Original Article

Transperitoneal laparoscopic adrenalectomy: five years' experience with 35 patients

1.

Third Department of Urology, Ministry of Health, Ankara Numune Research and Training Hospital, Ankara, Turkey

2.

Third Clinic of Urology, Ankara Numune Research and Training Hospital, Ministry of Health, Ankara, Turkey

3.

Department of Urology, Ankara Numune Training and Research Hospital, Ankara, Turkey,

4.

Department of Endocrinology and Metabolism, Ministry of Health, Ankara Numune Research and Training Hospital, Ankara, Turkey

5.

1Third Department of Urology, Ministry of Health, Ankara Numune Research and Training Hospital, Ankara, Turkey

Urol Res Pract 2013; 39: 214-219
DOI: 10.5152/tud.2013.056
Read: 1492 Downloads: 961 Published: 25 July 2019

Abstract

Objective: To present our laparoscopic surgery experience in the treatment of adrenal masses.

 

Material and methods: Between January 2008 and February 2013, a total of 35 patients (24 females, 11 males) underwent transperitoneal laparoscopic adrenalectomy to treat an adrenal mass. The patients underwent hormonal evaluation, chemical shift magnetic resonance imaging, or abdominal computerized tomography. Twenty-seven patients (77.1%) had a hormone-active adrenal mass. 

 

Results: Eighteen right, 16 left, and one bilateral transperitoneal laparoscopic adrenalectomies were performed. The mean age and body mass index of the patients were 47.4 years and 26.6 kg/m2, respectively. The mean adrenal mass size, operation time, estimated blood loss, and hospitalization duration were 41.9 mm, 94.7 min, 30 cc, and 2.4 d, respectively. No minor or major complications were observed perioperatively or postoperatively. In 1 patient (2.8%), the laparoscopic approach was converted to open surgery due to severe bradycardia resulting from chronic obstructive pulmonary disease. Histopathological examinations revealed adrenocortical hyperplasia in 23 (66%) patients, benign pheochromocytoma in 8 (22.8%) patients, and periadrenal paraganglioma, adrenocortical carcinoma, myeloid metaplasia, and myelolipoma in 1 (2.8%) patient each.

 

Conclusion: Transperitoneal laparoscopic adrenalectomy is a safe and efficient minimally invasive treatment option with a low morbidity rate in the surgical treatment of adrenal masses.

Files
EISSN 2980-1478